A Review of Major Markets for Medical Lasers


Recent advances in laser technology are creating attractive opportunities in a market which is set to double in size to over $1000 million by the year 2001.

But which segments of this rapidly growing sector represent the best opportunities for future investment and market share growth?

Everything you need to know...

A timely 192-page report from Clinica Reports offers a comprehensive analysis of the medical laser market and provides an essential overview of the current state of the industry. It addresses the key issues and answers your questions including:

Don't miss out on your guide to this exciting industry order your copy today.

Published: July 1996
Pages: 192
Ref: CBS639E
Price: £210/$440/¥50,000

For further information about this report, please contact our Customer Helpdesk on:
Tel: +44 (0)20 8332 8965 / 66
Fax: +44 (0)20 8332 8992
E-mail: [email protected]

TABLE OF CONTENTS

EXECUTIVE SUMMARY
ES.1 The focus of the report
ES.2 The structure of the report

CHAPTER 1 INTRODUCTION
1.1 The methods used to collate this report
1.2 The industry
1.3 The regulatory and reimbursement environment
1.4 The impact of macroeconomics
1.5 The impact of technology development
1.6 The impact of end-user need
1.7 Market size and growth forecasts
1.8 Market shares of leading companies
1.9 Business development

CHAPTER 2 DEFINITIONS
2.1 Acronyms used in the industry
2.2 Abbreviations used in this report
2.3 Dollar conversions
2.4 Product segmentation
2.5 Geographical market segmentation

CHAPTER 3 PRODUCTS AND SUPPLIERS
3.1 An introduction to lasers
3.2 A summary of core technologies
3.2.1 CO2 and Nd:YAG lasers
3.2.2 Ho:YAG lasers
3.2.3 Diode lasers
3.2.4 Other lasers
3.3 Lasers in ophthalmology
3.3.1 Photo-coagulation
3.3.2 Photo-disruption
3.3.3 Refraction correction
3.3.4 Ophthalmic photo-dynamic therapy
3.3.5 Ophthalmic diagnostics
3.4 Lasers in dentistry
3.5 Lasers in dermatologic and plastic surgery
3.6 Photo-dynamic and other cancer therapy
3.6.1 The technology
3.6.2 Types of lasers used for photo-dynamic therapy
3.7 Lasers for biostimulation
3.7.1 Applications of biostimulation lasers
3.7.2 Types of lasers used for biostimulation
3.8 Surgical lasers
3.9 Other technologies competing with lasers
3.10 The product supply base
3.10.1 Leading companies
3.10.2 Companies and products
3.11 Product pricing
3.12 Industry concerns
3.12.1 Cost-containment and the quality of healthcare
3.12.2 Managed care
3.12.3 Day-surgery and out-patient treatment
3.12.4 Over-supply
3.12.5 High-cost and high-risk advanced technology
3.12.6 The cyclical peak
3.12.7 Supplier alliances

CHAPTER 4 MARKET DYNAMICS
4.1 Overview
4.1.1 The strongest influences
4.1.2 The general background
4.2 The impact of technology development
4.2.1 Diode-laser technology
4.2.2 Ophthalmic lasers
4.2.3 Lasers for aesthetic treatment
4.2.4 Photo-dynamic therapy
4.2.5 Alternative technology
4.3 The economic climate
4.3.1 Europe
4.3.1.1 Germany
4.3.1.2 France
4.3.1.3 Italy
4.3.1.4 United Kingdom
4.3.1.5 Japan
4.3.1.6 United States
4.4 Regulatory influences on market development
4.4.1 Reimbursement
4.4.2 Regulations
4.4.2.1 Overview
4.4.2.2 Change in Europe
4.5 End-user needs
4.5.1 The needs of the clinician
4.5.2 Demand
4.5.2.1 The elderly
4.5.2.2 Congenital or minor acquired defects
4.5.2.3 Clinical defects

CHAPTER 5 THE MARKET SIZE
5.1 Overview of the market dynamics
5.2 The global market
5.3 Detailed forecasts
5.4 The trends in annual growth

CHAPTER 6 ESTIMATED MARKET SHARES OF LEADING COMPANIES
6.1 Overview of the market
6.2 Market shares
6.2.1 Lasers in all healthcare applications
6.2.2 Medical lasers

CHAPTER 7 MARKET SUCCESS FACTORS
7.1 Overview of the market
7.2 Market attractiveness
7.3 Success factors

CHAPTER 8 PROFILES OF SELECTED COMPANIES
8.1 Introduction
8.2 Profiles
8.2.1 Aesculap AG
8.2.2 B&K Medical A/S
8.2.3 Candela Laser Corporation
8.2.4 Carl Zeiss
8.2.5 Ceram Optec GmbH
8.2.6 Coherent Inc
8.2.7 Diomed Ltd
8.2.8 Dornier Medizintechnik GmbH
8.2.9 Heraeus Surgical Inc
8.2.10 Keeler Instruments Ltd
8.2.11 Lasermatic Oy
8.2.12 Laserscope Inc
8.2.13 Laser Industries Ltd
8.2.14 Lynton Lasers Ltd
8.2.15 3M Corporation
8.2.16 Martin Medizin-Technik
8.2.17 Summit Technology Inc
8.2.18 Vida Elettronica SRL
8.2.19 VISX Inc
8.3 Other listed players marketing in recent years
8.3.1 Adlas GmbH
8.3.2 Advanced Laser Technology Inc
8.3.3 Agnis
8.3.4 Aplicaciones de Ingenieria Electromedica
8.3.5 ATONOS Optische Technologien
8.3.6 Big Sky Laser Technologies Inc
8.3.7 Biolase Technology Inc
8.3.8 Carl Baasel Lasertechnik GmbH
8.3.9 CJ Laser Corporation
8.3.10 DEKA mela SRL
8.3.11 Dynamic Light Ltd
8.3.12 Etoile Snc di A Lazzari & C
8.3.13 Excel Technology Inc
8.3.14 The Excimer Laser Company
8.3.15 Herbert Schwind GmbH & Co KG
8.3.16 HGM Medical Lasers Inc
8.3.17 Intelligent Surgical Lasers
8.3.18 Laser Instruments
8.3.19 Lasering SRL
8.3.20 Lasotronic AG
8.3.21 Nidek Inc
8.3.22 Novatec Laser Systems
8.3.23 NWL Laser-Technologie GmbH
8.3.24 Oxford Lasers Ltd
8.3.25 Palomar Medical Technologies
8.3.26 PDT Systems
8.3.27 QLT Phototherapeutics (formerly Quadra Logic)
8.3.28 Satelec
8.3.29 Spectrum Medical Technologies Inc
8.3.30 Sunrise Technologies Inc
8.3.31 Team Laser SRL 175
8.3.32 Techno-2000 176
8.3.33 TecnoGamma SNC 176
8.4 List of locations for selected companies with high profiles in the market 176

LIST OF TABLES
Table ES.1 The geographical focus of the report
Table 1.1 Real GDP growth in the major country markets (1995-2000)
Table 1.2 Estimated total world sales revenues (1995-2001) ($ million)
Table 1.3 Estimated world market value by region (1995-2001) ($ million)
Table 1.4 Total world sales by product type (1995-2001) ($ million)
Table 1.5 Leaders in medical lasers worldwide (1995)
Table 2.1 List of technical acronyms
Table 2.2 List of relevant key definitions in laser therapy and competitive techniques
Table 2.3 List of general abbreviations
Table 2.4 Key conversion factors to US dollars (1995 calendar average)
Table 2.5 An applications segmentation
Table 2.6 Geographical segmentation
Table 3.1 Examples of applications of lasers in healthcare
Table 3.2 Core technology and application
Table 3.3 The early history of lasers
Table 3.4 Selected examples of laser types used in healthcare
Table 3.5 Applications for biostimulation lasers
Table 3.6 Examples of reported biochemical and physiological effects of low-level lasers
Table 3.7 Leading companies in the global markets (1995)
Table 3.8 The technology focus of selected + laser companies (1996)
Table 3.9 The application focus of selected medical laser companies (1996)
Table 3.10 Suppliers of biostimulation lasers
Table 3.11 Relative prices in 1995
Table 4.1 Indicators of the size of healthcare system by region
Table 4.2 Key indicators of the extent of the health system for Germany and OECD countries
Table 4.3 Medium-term economic forecasts for Germany
Table 4.4 Key indicators of the extent of the health system for France and competitive OECD countries
Table 4.5 Medium-term economic forecasts for France
Table 4.6 Key indicators of the extent of the health system for Italy and competitive OECD countries
Table 4.7 Medium-term economic forecasts for Italy
Table 4.8 Key indicators of the extent of the health system for the UK and competitive OECD countries
Table 4.9 Medium-term economic forecasts for the UK
Table 4.10 Key indicators of the extent of the health system for OECD countries
Table 4.11 Medium-term economic forecasts for Japan
Table 4.12 Key indicators of the extent of the health system for the US and competitive OECD countries
Table 4.13 Medium-term economic forecasts for the US
Table 4.14 An outline of the EU Medical Devices Directive
Table 5.1 Estimated total world sales revenues (1995-2001) ($ million)
Table 5.2 Estimated world market value by region (1995-2001) ($ million)
Table 5.3 Total world sales by product type (1995-2001) ($ million)
Table 5.4 Estimated proportions of unit sales of medical laser systems by technology (1995 and 2001)
Table 5.5 Germany - the market to 2001 ($ million)
Table 5.6 France - the market to 2001 ($ million)
Table 5.7 Italy - the market to 2001 ($ million)
Table 5.8 UK - the market to 2001 ($ million)
Table 5.9 Japan - the market to 2001 ($ million)
Table 5.10 US - the market to 2001 ($ million)
Table 5.11 The market for ophthalmic laser products to 2001 ($ million)
Table 5.12 The market for dermatologic laser products (including aesthetic applications) to 2001 ($ million)
Table 5.13 The market for PDT laser hardware to 2001 ($ million)
Table 5.14 The market for dental laser products to 2001 ($ million)
Table 5.15 The market for biostimulation laser products to 2001 ($ million)
Table 5.16 Total and biennial market growth by region, 1995-2001
Table 5.17 Total and biennial market growth by product application
Table 6.1 Estimated revenues for leading healthcare laser companies
Table 6.2 Leaders in medical lasers worldwide (1995)
Table 8.1 Summary of companies profiled
Table 8.2 Candela Laser Corporation - financial performance (1991-1995)
Table 8.3 Carl Zeiss - sales revenues (1992-1994)
Table 8.4 Coherent Inc - financial highlights
Table 8.5 Laser Industries - financial summary
Table 8.6 3M - financial profile (1993-1995)
Table 8.7 3M - net sales ($ million) by product group (1993-1995)
Table 8.8 Summit Technology - financial summary (1990-1995)
Table 8.9 ISL net loss
Table 8.10 Examples of companies actively marketing laser products from 1992 onwards

LIST OF FIGURES
Figure 1.1 Estimated total world sales revenues (1995-2001) ($ million)
Figure 1.2 Estimated world market value by region (1995-2001) ($ million)
Figure 1.3 Total world sales by product type (1995-2001) ($ million)
Figure 1.4 Leaders in medical lasers worldwide (1995)
Figure 3.1 Estimated distribution of surgical laser types (1995)
Figure 3.2 Estimated distribution of application disciplines for surgical lasers (1995)
Figure 4.1 The western European population
Figure 4.2 Growth of population older than 65 yrs (as % of total population) in major population centres
Figure 4.3 Total expenditure on healthcare for Germany and competitive nations ($ million)
Figure 4.4 Total expenditure on healthcare (as a % of GDP) for Germany and competitive nations
Figure 4.5 The number of active physicians registered in the total health system in Germany and competitive nations
Figure 4.6 Medium-term economic forecasts for Germany
Figure 4.7 Total expenditure on healthcare ($ million) in France and competitive nations
Figure 4.8 Total expenditure on healthcare (as a % of GDP) in France and competitive nations
Figure 4.9 Total expenditure on therapeutic appliances ($ million)
Figure 4.10 The number of active physicians registered in the total health system in France and competitive nations
Figure 4.11 Medium-term economic forecasts for France
Figure 4.12 Total expenditure on healthcare ($ million) in Italy and competitive OECD nations
Figure 4.13 Total expenditure on healthcare (as a % of GDP) in Italy and competitive OECD nations
Figure 4.14 Total expenditure on therapeutic appliances ($ million) in Italy and competitive OECD nations
Figure 4.15 The number of active physicians registered in the total health system in Italy and competitive OECD nations
Figure 4.16 Medium-term economic forecasts for Italy
Figure 4.17 Total expenditure on healthcare ($ million) in the UK and for competitive OECD nations
Figure 4.18 Total expenditure on healthcare (as a % of GDP) in the UK and for competitive OECD nations
Figure 4.19 The number of active physicians registered in the total health system in the UK and in competitive OECD nations
Figure 4.20 Medium-term economic forecasts for the UK
Figure 4.21 Total expenditure on healthcare ($ million) in Japan and in competitive OECD nations
Figure 4.22 Total expenditure on healthcare (as a % of GDP) in Japan and in competitive OECD nations
Figure 4.23 Total expenditure on therapeutic appliances ($ million) in Japan and in competitive OECD nations
Figure 4.24 The number of practising physicians registered in the total health system in Japan and in competitive OECD nations
Figure 4.25 Medium-term economic forecasts for Japan
Figure 4.26 Total expenditure on healthcare ($ million) in the US and in competitive OECD nations
Figure 4.27 Total expenditure on healthcare (as a % of GDP) in the US and in competitive OECD nations
Figure 4.28 Total expenditure on therapeutic appliances ($ million) in the US and in competitive OECD nations
Figure 4.29 The number of practising physicians registered in the total health system in the US and in competitive OECD nations
Figure 4.30 Medium-term economic forecasts for the US 97
Figure 5.1 Estimated total world sales revenues (1995-2001) ($ million)
Figure 5.2 Comparative world sales revenues split by region (1995 and 2001) (% of total)
Figure 5.3 Estimated world market value by region (1995-2001) ($ million)
Figure 5.4 Total world sales by product type (1995-2001) ($ million)
Figure 5.5 Growth in total world sales revenue by product type (1995-2001) (compound annual growth rate %)
Figure 5.6 Estimated proportions of unit sales of medical laser systems by technology (1995 and 2001)
Figure 5.7 Germany - the market to 2001 ($ million)
Figure 5.8 France - the market to 2001 ($ million)
Figure 5.9 Italy - the market to 2001 ($ million)
Figure 5.10 UK - the market to 2001 ($ million)
Figure 5.11 Japan - the market to 2001 ($ million)
Figure 5.12 US - the market to 2001 ($ million)
Figure 5.13 The market for ophthalmic laser products to 2001 ($ million)
Figure 5.14 The market for dermatologic laser products (including aesthetic applications) to 2001 ($ million)
Figure 5.15 The market for PDT laser hardware to 2001 ($ million)
Figure 5.16 The market for dental laser products to 2001 ($ million)
Figure 5.17 The market for biostimulation laser products to 2001 ($ million)
Figure 6.1 Estimated sales revenues by product type (1995-2001) ($ million)
Figure 6.2 Estimated total sales revenues by region (1995-2001) ($ million)
Figure 7.1 Relative market size and growth
Figure 7.2 Regional market attractiveness
Figure 8.1 Summary of Aesculap's principal shareholding earnings (1993/1994)
Figure 8.2 Carl Zeiss - approximate sales by product type

© PJB Publications Ltd. 2001
All rights reserved.